Dr. John M. Prince JR., MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Virginia School of Medicine (1980)
- Years since graduation
- 46
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 354
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1980Medical school: University of Virginia School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
TN license 22127 -
Critical Care Medicine (Internal Medicine) Physician
TN license 22127
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Parkwest Medical Center Knoxville, TN
- Fort Sanders Regional Medical Center Knoxville, TN
- Physicians Regional Medical Center Powell, TN
- Fort Loudoun Medical Center Lenoir City, TN
- Cumberland Medical Center Crossville, TN
Medical groups
- Statcare Outpatient LLC (28 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 354
- Services billed
- 36,766
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, benralizumab, 1 mg | 1,230 | 19 |
| Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | 1,200 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 222 | 128 |
| Test to measure expiratory airflow and volume | 183 | 159 |
| Established patient office or other outpatient visit, 20-29 minutes | 155 | 117 |
| Test to examine how well the lungs exchange gases | 139 | 126 |
| Test to determine lung volumes using gas dilution or washout | 135 | 122 |
| X-ray of chest, 2 views | 127 | 109 |
| Test to measure the level of nitric oxide gas | 84 | 70 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 73 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Knoxville, TN | 287 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Knoxville, TN | 151 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Knoxville, TN | 118 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Knoxville, TN | 112 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Knoxville, TN | 86 |
| Prednisone Other prescribers in Knoxville, TN | 63 |
| Azithromycin Other prescribers in Knoxville, TN | 49 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Knoxville, TN | 42 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Knoxville, TN | 35 |
| Ipratropium Bromide Other prescribers in Knoxville, TN | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 132 payments worth $19,594 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $10,878 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $6,781 |
| GlaxoSmithKline, LLC. | $400 |
| Amgen Inc. | $272 |
| Insmed, Inc. | $248 |
| Actelion Pharmaceuticals US, Inc. | $149 |
| Genzyme Corporation | $136 |
| Galvanize Therapeutics, Inc | $116 |
| Compensation for services other than consulting (speaking, faculty) | $16,033 |
|---|---|
| Food and Beverage | $3,549 |
| Education | $11.56 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Sep 19, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $4,040 |
| Regeneron Healthcare Solutions, Inc. Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,778 |
| Regeneron Healthcare Solutions, Inc. Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,778 |
| AstraZeneca Pharmaceuticals LP Jan 22, 2025 | Compensation for services other than consulting (speaking, faculty) BREZTRI · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| AstraZeneca Pharmaceuticals LP Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,760 |
| AstraZeneca Pharmaceuticals LP Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,760 |
| Regeneron Healthcare Solutions, Inc. Oct 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $842 |
| AstraZeneca Pharmaceuticals LP Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $100 |
| AstraZeneca Pharmaceuticals LP Jul 24, 2025 | Education BREZTRI · Respiratory · in-kind Company’s descriptionJournal Article | $11.56 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.